The largest database of trusted experimental protocols

Recombinant human fgf basic

Manufactured by Proteintech

Recombinant human FGF basic is a protein that belongs to the fibroblast growth factor (FGF) family. It is produced using recombinant DNA technology. FGF basic is a signaling molecule that plays a role in various cellular processes, including cell proliferation, differentiation, and angiogenesis.

Automatically generated - may contain errors

2 protocols using recombinant human fgf basic

1

Characterization of hESC Lines for Research

Check if the same lab product or an alternative is used in the 5 most similar protocols
The hESC lines in this study are as follows: UCLA1 (46, XX), UCLA2 (46, XY)(Diaz Perez et al., 2012 (link)), UCLA8 (46, XX)(Chen et al., 2017 (link)), and H1 OCT4-GFP (H1) (46, XY)(Gkountela et al., 2015 (link)). All hESCs were cultured on mitomycin C-inactivated mouse embryonic fibroblasts (MEFs) and split every 7 days using Collagenase type IV (GIBCO, 17104–019). hESC media was comprised of 20% knockout serum replacement (KSR) (GIBCO, 10828–028), 100mM L-Glutamine (GIBCO,25030–081), 1x MEM Non-Essential Amino Acids (NEAA) (GIBCO, 11140–050), 55mM 2-Mercaptoethanol (GIBCO, 21985–023), 10ng/mL recombinant human FGF basic (Proteintech HZ1285), 1x Penicillin-Streptomycin (GIBCO, 15140–122), and 50ng/mL primocin (InvivoGen, ant-pm-2) in DMEM/F12 media (GIBCO, 11330–032). All hESC lines used in this study are registered with the National Institute of Health Human Embryonic Stem Cell Registry and are available for research use with NIH funds. hESCs used in this study were routinely tested for mycoplasma (Lonza, LT07–418). All experiments were approved by the UCLA Embryonic Stem Cell Research Oversight Committee.
+ Open protocol
+ Expand
2

Culturing Primed Human Embryonic Stem Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
UCLA2 and UCLA1 hESC are cultured as previously described16 (link), briefly the hESCs are cultured in hESC media, which was composed of 20% knockout serum replacement (KSR) (Life Technologies, A3181502), 1x MEM Non-Essential Amino Acids (NEAA) (Fisher Scientific, 25-025-CI), 1x Penicillin/Streptomycin/Glutamine (Thermo Fisher, 10378016), 55 µM 2- Mercaptoethanol (Life Technologies, 21985-023), 10 ng/mL recombinant human FGF basic (Proteintech, HZ1285), and 50 ng/mL primocin (InvivoGen, ant-pm-2) in DMEM/F12 media (GIBCO, 11330-032). The primed hESCs were split by 1 mg/ml Collagenase type IV (GIBCO, 17104-019) and maintained routinely on mitomycin C (MMC)-inactivated mouse embryonic fibroblasts (MEFs). The hESCs were split every 7 days using Collagenase type IV (GIBCO, 17104-019). HEK293 cells were acquired from ATCC (Cat# CRL-3216). No lines used in this study belong to the International Cell Line Authentication Committee register of misidentified cell lines.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!